Report Detail
Global Anti-Obesity Prescription Market Professional Survey Report 2019
- RnM3785019 |
- 26 September, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Pharma & Healthcare
Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.
There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.
The global Anti-Obesity Prescription market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Obesity Prescription volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Obesity Prescription market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Obesity Prescription in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Obesity Prescription manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Zydus Cadila
Akrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Table of Contents
Executive Summary
1 Industry Overview of Anti-Obesity Prescription
- 1.1 Definition of Anti-Obesity Prescription
- 1.2 Anti-Obesity Prescription Segment by Type
- 1.2.1 Global Anti-Obesity Prescription Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Bupropion and Naltrexone
- 1.2.3 Orlistat
- 1.2.4 Lorcaserin
- 1.2.5 Phentermine and Topiramate
- 1.2.6 Liraglutide
- 1.3 Anti-Obesity Prescription Segment by Applications
- 1.3.1 Global Anti-Obesity Prescription Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 E-Commerce
- 1.4 Global Anti-Obesity Prescription Overall Market
- 1.4.1 Global Anti-Obesity Prescription Revenue (2014-2025)
- 1.4.2 Global Anti-Obesity Prescription Production (2014-2025)
- 1.4.3 North America Anti-Obesity Prescription Status and Prospect (2014-2025)
- 1.4.4 Europe Anti-Obesity Prescription Status and Prospect (2014-2025)
- 1.4.5 China Anti-Obesity Prescription Status and Prospect (2014-2025)
- 1.4.6 Japan Anti-Obesity Prescription Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anti-Obesity Prescription Status and Prospect (2014-2025)
- 1.4.8 India Anti-Obesity Prescription Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anti-Obesity Prescription
- 2.3 Manufacturing Process Analysis of Anti-Obesity Prescription
- 2.4 Industry Chain Structure of Anti-Obesity Prescription
3 Development and Manufacturing Plants Analysis of Anti-Obesity Prescription
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anti-Obesity Prescription Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anti-Obesity Prescription
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anti-Obesity Prescription Production and Capacity Analysis
- 4.2 Anti-Obesity Prescription Revenue Analysis
- 4.3 Anti-Obesity Prescription Price Analysis
- 4.4 Market Concentration Degree
5 Anti-Obesity Prescription Regional Market Analysis
- 5.1 Anti-Obesity Prescription Production by Regions
- 5.1.1 Global Anti-Obesity Prescription Production by Regions
- 5.1.2 Global Anti-Obesity Prescription Revenue by Regions
- 5.2 Anti-Obesity Prescription Consumption by Regions
- 5.3 North America Anti-Obesity Prescription Market Analysis
- 5.3.1 North America Anti-Obesity Prescription Production
- 5.3.2 North America Anti-Obesity Prescription Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anti-Obesity Prescription Import and Export
- 5.4 Europe Anti-Obesity Prescription Market Analysis
- 5.4.1 Europe Anti-Obesity Prescription Production
- 5.4.2 Europe Anti-Obesity Prescription Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anti-Obesity Prescription Import and Export
- 5.5 China Anti-Obesity Prescription Market Analysis
- 5.5.1 China Anti-Obesity Prescription Production
- 5.5.2 China Anti-Obesity Prescription Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anti-Obesity Prescription Import and Export
- 5.6 Japan Anti-Obesity Prescription Market Analysis
- 5.6.1 Japan Anti-Obesity Prescription Production
- 5.6.2 Japan Anti-Obesity Prescription Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anti-Obesity Prescription Import and Export
- 5.7 Southeast Asia Anti-Obesity Prescription Market Analysis
- 5.7.1 Southeast Asia Anti-Obesity Prescription Production
- 5.7.2 Southeast Asia Anti-Obesity Prescription Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anti-Obesity Prescription Import and Export
- 5.8 India Anti-Obesity Prescription Market Analysis
- 5.8.1 India Anti-Obesity Prescription Production
- 5.8.2 India Anti-Obesity Prescription Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anti-Obesity Prescription Import and Export
6 Anti-Obesity Prescription Segment Market Analysis (by Type)
- 6.1 Global Anti-Obesity Prescription Production by Type
- 6.2 Global Anti-Obesity Prescription Revenue by Type
- 6.3 Anti-Obesity Prescription Price by Type
7 Anti-Obesity Prescription Segment Market Analysis (by Application)
- 7.1 Global Anti-Obesity Prescription Consumption by Application
- 7.2 Global Anti-Obesity Prescription Consumption Market Share by Application (2014-2019)
8 Anti-Obesity Prescription Major Manufacturers Analysis
- 8.1 Zydus Cadila
- 8.1.1 Zydus Cadila Anti-Obesity Prescription Production Sites and Area Served
- 8.1.2 Zydus Cadila Product Introduction, Application and Specification
- 8.1.3 Zydus Cadila Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Akrimax Pharmaceuticals
- 8.2.1 Akrimax Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
- 8.2.2 Akrimax Pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Zealand Pharma
- 8.3.1 Zealand Pharma Anti-Obesity Prescription Production Sites and Area Served
- 8.3.2 Zealand Pharma Product Introduction, Application and Specification
- 8.3.3 Zealand Pharma Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Arrowhead Research
- 8.4.1 Arrowhead Research Anti-Obesity Prescription Production Sites and Area Served
- 8.4.2 Arrowhead Research Product Introduction, Application and Specification
- 8.4.3 Arrowhead Research Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Arena Pharmaceuticals
- 8.5.1 Arena Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
- 8.5.2 Arena Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Compellis Pharmaceuticals
- 8.6.1 Compellis Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
- 8.6.2 Compellis Pharmaceuticals Product Introduction, Application and Specification
- 8.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Yungjin Pharm
- 8.7.1 Yungjin Pharm Anti-Obesity Prescription Production Sites and Area Served
- 8.7.2 Yungjin Pharm Product Introduction, Application and Specification
- 8.7.3 Yungjin Pharm Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Alpex Pharma
- 8.8.1 Alpex Pharma Anti-Obesity Prescription Production Sites and Area Served
- 8.8.2 Alpex Pharma Product Introduction, Application and Specification
- 8.8.3 Alpex Pharma Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bridge BioResearch
- 8.9.1 Bridge BioResearch Anti-Obesity Prescription Production Sites and Area Served
- 8.9.2 Bridge BioResearch Product Introduction, Application and Specification
- 8.9.3 Bridge BioResearch Anti-Obesity Prescription Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Anti-Obesity Prescription Market
- 9.1 Global Anti-Obesity Prescription Market Trend Analysis
- 9.1.1 Global Anti-Obesity Prescription Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anti-Obesity Prescription Regional Market Trend
- 9.2.1 North America Anti-Obesity Prescription Forecast 2019-2025
- 9.2.2 Europe Anti-Obesity Prescription Forecast 2019-2025
- 9.2.3 China Anti-Obesity Prescription Forecast 2019-2025
- 9.2.4 Japan Anti-Obesity Prescription Forecast 2019-2025
- 9.2.5 Southeast Asia Anti-Obesity Prescription Forecast 2019-2025
- 9.2.6 India Anti-Obesity Prescription Forecast 2019-2025
- 9.3 Anti-Obesity Prescription Market Trend (Product Type)
- 9.4 Anti-Obesity Prescription Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anti-Obesity Prescription Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Anti-Obesity Prescription. Industry analysis & Market Report on Anti-Obesity Prescription is a syndicated market report, published as Global Anti-Obesity Prescription Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Anti-Obesity Prescription market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
